Anticancer agent 51
Anticancer agent 51 (compound 3d) is a potent anticancer agent with an Ki of 731.62 nM. Anticancer agent 51 shows anticancer activity. Anticancer agent 51 has the potential for the research of prostate cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2521777-38-6
- Fòrmula: C22H20F3N3O2S
- Peso molecular:447.47
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
62.2 μM
Compound: 3d; SGK-606
|
Cytotoxicity against human DU-145 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human DU-145 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 32998089] |
| LNCaP | IC50 |
92.8 μM
Compound: 3d; SGK-606
|
Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human LNCaP cells assessed as reduction in cell viability by MTT assay
|
[PMID: 32998089] |
| PC-3 | IC50 |
64.3 μM
Compound: 3d; SGK-606
|
Cytotoxicity against human PC-3 cells assessed as reduction in cell viability by MTT assay
Cytotoxicity against human PC-3 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 32998089] |
Anticancer agent 51 (compound 3d) shows anticancer activity with IC50s of 64.3, 62.2, 92.8 μM for PC-3, DU-145, LNCaP cells, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2521777-38-6
-
Peso molecular 447.47
-
Fòrmula C22H20F3N3O2S
-
SMILES
FC(F)(F)C(C=C1)=CC=C1NC(NNC([C@H](C2=CC3=C(C=C2)C=C(C=C3)OC)C)=O)=S
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)